Asymbescaline: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Asymbescaline": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == | ||
Latest revision as of 14:32, 4 September 2012
| Asymbescaline | |
|---|---|
| Chemical name | 3,4-diethoxy-5-methoxyphenethylamine or 2-(3,4-diethoxy-5-methoxyphenyl)ethanamine |
| Chemical formula | C13H21NO3 |
| Molecular mass | 239.31 g/mol |
| SMILES | CCOc1c(cc(cc1OCC)CCN)OC |
| File:Asymbescaline.png File:Asymbescaline-3d-sticks.png | |
Asymbescaline, or 3,4-diethoxy-5-methoxyphenethylamine, is a lesser-known psychedelic drug. It is a homologue of Mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 200-280 mg, and the duration listed as 10-15 hours. Asymbescaline produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Asymbescaline.